Hepatorenal syndrome
Supplements studied for hepatorenal syndrome.
Overview
Only N-Acetyl Cysteine (NAC) is indexed for hepatorenal syndrome (1 study; DEX Score 40; low effect size, low evidence, low trust). A small report evaluated intravenous NAC in people with this condition, where kidney and liver function both decline.
NAC appeared to improve kidney function slightly and was linked to longer survival in that report, but it did not help liver function or blood pressure. With only one small study available, it remains unclear whether NAC is beneficial, and more studies are needed. See the evidence review below.
Effect graph
Subscribe to access all content
Interactive visualisations of ranked conditions and clinical benefit with purchase guidance.
Already a subscriber? Sign in
Relevant supplements heatmap
Relevant supplements sorted by DEX Score.
Subscribe to access all content
See effect size, evidence strength, and trust at a glance for every condition.
Already a subscriber? Sign in
SupplementDEX Database
1 supplement for rated at least stars. All purchase bands. No minimum star filter.
Subscribe to access all content
Read this and 2,600+ other evidence reviews on our practitioner plan.
Already a subscriber? Sign in
Evidence visualised
Subscribe to view condition evidence
Visual summaries of supplement evidence ranked by condition.
Already a subscriber? Sign in